Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells
1996

VEGF Expression in Prostate Tumors and Neuroendocrine Cells

Sample size: 55 publication Evidence: moderate

Author Information

Author(s): ME Harper, E Glynne-Jones, L Goddard, VJ Thurston, K Griffiths

Primary Institution: Tenovus Cancer Research Centre, University of Wales College of Medicine

Hypothesis

Is there a relationship between VEGF expression and neuroendocrine cells in prostatic tumors?

Conclusion

The study found that most prostatic tumors express VEGF, which may aid in their neovascularization, and that neuroendocrine cells in these tumors express high levels of VEGF.

Supporting Evidence

  • The majority of carcinoma specimens exhibited cytoplasmic staining for VEGF.
  • A significant correlation between the total number of intensely stained VEGF-positive cells and chromogranin A-positive cells was found.
  • VEGF expression increased with dedifferentiation of the tumors.

Takeaway

This study shows that a lot of prostate tumors have a special protein called VEGF that helps them grow new blood vessels, and some cells in these tumors that act like nerve cells also make a lot of this protein.

Methodology

Immunohistochemical analysis was performed on prostatic carcinoma specimens and benign prostatic hyperplasia to assess VEGF expression.

Participant Demographics

Patients with histologically diagnosed prostatic carcinoma and benign prostatic hyperplasia.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication